Funders to approach for Rare Bird Foundation
Working with our partners worldwide , Rare Bird aims to create the first-ever globally approved drug to tackle the transcription factor Myocyte Enhancer Factor 2C MEF2C deficiency within five years.
Your prospects by chance and grant size
a funder to approach
$20k, your typical grantunder 1 in 100$1k$3k$10k$30k$100kChance of a first grant within two years →Likely grant for you →
Chance of any first grant1 in 10in the next two years, expected value $3k
Last two years (2023–24)$0from 0 new funders
Half the value is in your top 7 funders, of 158
FunderWay inChanceLikely grant
- 1Rare Village FoundationSimilar grantees: Riaan Research Initiative Inc ($1.0M/yr), Raiden Science Foundation ($180k/yr)under 1 in 100$87k
- 2Global GenesSimilar grantees: Nr2f1 Foundation ($9k/yr), Hereditary Neuropathy Foundation Inc ($9k/yr), Myhre Syndrome Foundation ($15k/yr)under 1 in 100$10k
- 3The Cooperative Impact LabSimilar grantees: CACNA1A Foundation ($6k/yr), Usher 1F Collaborative Inc ($9k/yr), Project 8p Foundation ($9k/yr)under 1 in 100$13k
155 more funders on the list for Rare Bird Foundation
The full ranking, every way in, an approach plan for each funder and the CSV are included from the $75 plan up.